-

10:28:44 PM

BHC Stock News

BHC - Bausch Health Companies Inc

06/23/22 4:54 PM

NYSE : BHC

management

Bausch Health Announces 2022 Annual Meeting of Shareholder Results, Updates to its Board of Directors

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced the results of its 2022 annual meeting of shareholders and certain other updates with respect to the Company's Board of Directors (the "Board").Annual Meeting

RHEA-AI

neutral

06/21/22 7:00 AM

NYSE : BHC

Bausch Health Issues Form 8-K for 2022 Annual Meeting of Shareholders Presentation

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced the Company is providing a presentation on its business during the Company's Annual Meeting of Shareholders on June 21, 2022. The presentation will be available

RHEA-AI

neutral

06/20/22 7:00 AM

NYSE : BHC

clinical trial

Salix to Share New Data from XIFAXAN® (Rifaximin) Clinical Research at EASL's International Liver Congress™ 2022

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its gastroenterology business, Salix Pharmaceuticals, ("Salix"), one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of

RHEA-AI

neutral

06/16/22 5:30 PM

NYSE : BHC

Bausch Health Provides Update on Solta Medical

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced an update on its previously stated plan to pursue an initial public offering (IPO) of its Solta Medical business ("Solta"). Solta is a leading global provider in

RHEA-AI

positive

05/18/22 7:00 AM

NYSE : BHC

Salix Pharmaceuticals To Share New Data At Digestive Disease Week® 2022

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its gastroenterology business, Salix Pharmaceuticals, ("Salix"), one of the largest specialty

RHEA-AI

neutral

05/12/22 6:05 PM

Nasdaq : PACW, KBRA, BHC

KBRA Releases U.S. Bank 1Q22 Compendium

The Compendium provides our latest view of the U.S. banking sector and analyzes the 1 Q22 results of U.S. banks with KBRA long-term ratings. In addition, the Compendium includes our quarterly environmental, social, and governance Bulletin, which features PacWest Bancorp. The Compendium includes 1 Q22 summaries on all publicly traded U.S. banks in KBRA’ s rated...

RHEA-AI

neutral

05/11/22 7:00 AM

NYSE : BHC

conferences

Bausch Health Announces Participation In Upcoming Investor Conferences

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced that the Company will participate in several upcoming investor conferences.Tom Vadaketh, executive vice president and chief financial officer; William Woodfield,

RHEA-AI

neutral

05/10/22 12:46 PM

NYSE : BHC, BLCO

IPOoffering

Bausch Health And Bausch + Lomb Corporation Announce Closing Of Initial Public Offering Of Bausch + Lomb And Related Debt Transactions

Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb") and Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") today announced the closing of the initial public offering ("IPO") of Bausch + Lomb. A wholly owned subsidiary of

RHEA-AI

very positive

05/10/22 6:59 AM

NYSE : BHC

Bausch Health Companies Inc. Announces First-Quarter 2022 Results

First-Quarter 2022 Financial Results Revenues of $1.918 Billion GAAP Net Loss of $69 Million Adjusted EBITDA (non-GAAP) 1 of $732 Million Bausch + Lomb Commences Trading Under "BLCO" Ticker Following IPO 2 Updates Full-Year Revenue and Adjusted EBITDA (non-GAAP) 1 Guidance Ranges LAVAL, QC, May 10,

RHEA-AI

neutral

05/06/22 12:08 PM

NYSE : BHC

Bausch Health Announces Thomas J. Appio As Chief Executive Officer

Bausch Health Companies Inc. (NYSE/TSX: BHC) (Bausch Health) today announced its full leadership team and Board of Directors, including Chief Executive Officer (CEO) Thomas J. Appio. 1 Upon completion of the initial public offering (IPO) of the Bausch + Lomb

RHEA-AI

very positive

1 2 3 4 5 6 7 8 9 10 Next

BHC Data

Websitewww.bauschhealth.com
Security nameBausch Health Companies Inc
Issue typecs
Sic code2834
Employees21600
Tags
- Health Technology
- Pharmaceuticals: Other
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Address2150 Saint-Elzear Blvd W
StateQuebec
CityLaval
ZipH7L 4A8
CountryCanada
Phone15147446792

About Bausch Health Companies Inc

Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health.